Since its founding in 2012, Northern Light Acadia Hospital Memory and Aging has made clinical research a cornerstone of its mission. From the start, our patients and their families have voiced a clear message: they want access to promising new therapies for Alzheimer’s disease and other related dementias—and they want to contribute to scientific knowledge to shape the future of brain health for their children, grandchildren, and generations to come.
In response to this powerful commitment, we established the Robert C. Strauss Neurocognitive Research Program, named in honor of a visionary donor. Today, it stands as the largest dementia clinical research program in Maine. Collaborating with the Northern Light Eastern Maine Medical Center Clinical Research Center, we have earned regional and national recognition.
We have completed more than 30 studies, partnering with major Alzheimer’s disease research consortia, including the Alzheimer’s Disease Collaborative Study at University of California at San Diego, the Alzheimer’s Disease Treatment and Research Initiative at University of Southern California, and international pharmaceutical and technology companies working on innovative approaches to slowing or preventing Alzheimer’s disease. Regionally, we have partnered with the University of Maine, the Clinical & Translational Research Unit at Massachusetts General Hospital, and the Jackson Lab. Together, we are advancing the science of memory and aging—with hope, purpose, and a deep commitment for more effective treatments for cognitive decline.